Recent Finacing
Recent Raise
Bellicum Pharmaceuticals develops drug-controlled cellular immunotherapies using CID-based switches (CaspaCIDe, DeCIDe) to enable activation or elimination of engineered T cells and dendritic vaccines for GVHD and oncology
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
